Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Rubius Therapeutics, Inc. (RUBY)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K10-K10-K10-K
Net income  -179.7-196.5-167.7-163.5-89.2-44.5-11.8
Depreciation and amortization  6.37.75.73.01.30.40.1
Stock-based compensation  15.835.633.741.327.517.90.1
Change in working capital   [+]-13.85.7-0.28.10.22.71.1
Other operating activities  21.32.40.90.61.91.50.9
Cash from operations  -150.1-145.1-127.6-110.4-58.3-21.9-9.5
   
Capital expenditures   [+]-5.3-3.6-5.5-40.7-15.0-2.3-0.4
Other cash from investing  0.385.0105.9-92.0-96.7  
Cash from investing  12.981.4100.4-132.6-111.6-2.3-0.4
   
Issuance of common stock, net  -75.7188.0 -0.1257.9  
Option exercises  0.211.01.52.40.10.1 
Financing costs   -0.2  -0.30.00.0
Other cash from financing  0.521.328.029.8116.7121.815.4
Cash from financing  -75.5198.526.527.3374.8121.715.4
   
Free cash flow  -155.4-148.8-133.1-151.1-73.3-24.2-9.9
        Per share (diluted)  ($1.72)($1.69)($1.65)($1.92)($1.87)($3.01)($1.38)
   
Cash paid for interest  4.45.13.83.00.40.30.1

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy